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Introduction
DNA replication is a key process that is functionally perturbed 
during DNA damage–triggered apoptosis (Burhans et al., 2003). 
DNA damage triggers apoptosis in a replication-dependent way 
by activating the mitochondrial damage pathway in fi  broblasts 
(Kaina, 2003). Chromosomal replication can be impaired by 
  intrinsic replication errors or by external agents that cause DNA 
damage (Hammond et al., 2002; Dodson et al., 2004).
Checkpoint-sensing kinases detect abnormal replication 
structures and activate the Chk2 kinase, which stabilizes repli-
cation forks and promotes recovery from DNA damage by 
phosphorylating downstream endonucleases, helicases, and re-
combinases, demonstrating that DNA replication forks are acti-
vators and effectors of the checkpoint pathway in S phase (Kai 
and Wang, 2003; Tercero et al., 2003). In response to a variety 
of DNA lesions in eukaryotic cells, DNA damage–sensing ki-
nases such as ataxia telangiectasia mutated (ATM), ATM and 
Rad-3 related (ATR), and DNA-dependent protein kinase are 
activated as checkpoint sensors that signal both the cell cycle 
and apoptosis machinery through the Chk1/2 checkpoint ki-
nases (Liu et al., 2000; Matsuoka et al., 2000; Shiloh, 2003). 
ATM and Chk2 directly phosphorylate p53, a key regulator of 
cellular responses to genotoxic stress. Phospho-p53 can then 
dissociate with the inhibitor protein Mdm2 and, thus, is stabi-
lized and transcriptionally activated for DNA damage responses 
(Shiloh, 2003; Pereg et al., 2005). The p53 protein also has a 
transcription-independent activity that potentiates cell death 
once transcription-dependent functions initiate this process 
(Haupt et al., 2003). Cytoplasmic p53 directly activates the pro-
apoptotic protein Bax through direct interaction (Schuler et al., 
2000; Chipuk et al., 2004).
Several lines of evidence indicate that replication initia-
tion is impaired in the early stages of apoptosis. First, apopto-
sis is induced by defects in the initiation of DNA replication 
as a result of the orc2-1 mutation (Weinberger et al., 2005). In 
addition, temperature-sensitive orc2-1 mutants cause a defect 
in a checkpoint and initiation of DNA replication (Weinberger 
et al., 1999; Trabold et al., 2005). Second, replication initiation 
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e show that caspase-3 cleaves Cdc6 at 
D
290/S and D
442/G sites, producing p32-
tCdc6 (truncated Cdc6) and p49-tCdc6, 
respectively, during etoposide- or tumor necrosis fac-
tor (TNF)-α–induced apoptosis. The expression of these 
tCdc6 proteins, p32- and p49-tCdc6, promotes etoposide-
  induced apoptosis. The expression of tCdc6 perturbs the 
loading of Mcm2 but not Orc2 onto chromatin and acti-
vates ataxia telangiectasia mutated (ATM) and ATM and 
Rad-3 related (ATR) kinase activities with kinetics similar 
to that of the phosphorylation of Chk1/2. The activa-
tion kinetics are consistent with elevated cellular levels of 
p53 and mitochondrial levels of Bax. The tCdc6-induced 
effects are all suppressed to control levels by expressing 
a Cdc6 mutant that cannot be cleaved by caspase-3 
(Cdc6-UM). Cdc6-UM expression attenuates the TNF-α–
induced activation of ATM and caspase-3 activities. 
When ATM or ATR is down-expressed by using the small 
interfering RNA technique, the TNF-α– or tCdc6-induced 
activation of caspase-3 activities is suppressed in the cells. 
These results suggest that tCdc6 proteins act as dominant-
  negative inhibitors of replication initiation and that they 
disrupt chromatin structure and/or induce DNA damage, 
leading to the activation of ATM/ATR kinase activation 
and p53–Bax-mediated apoptosis.
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  proteins such as Cdc6 and Mcm3 are cleaved by caspase early in 
apoptosis (Blanchard et al., 2002; Pelizon et al., 2002; Yim et al., 
2003; Schories et al., 2004). Third, when the expression of pro-
teins such as Cdc6, Mcm2, and Cdc45 is blocked by the siRNA 
technique, proliferation is inhibited, and apoptosis is induced in 
cancer cells (Feng et al., 2003). Thus, replication fork collapse 
induced by interfering with the pre–replicative complex (RC) 
may be a general feature of the early stages of apoptosis.
In a previous study, we showed that caspase-3–mediated 
cleavage of Cdc6 induces the nuclear retention of the truncated 
protein p49-tCdc6 (truncated Cdc6) and apoptosis (Yim et al., 
2003). We proposed that p49-tCdc6 acts as a dominant-negative 
inhibitor of replication that consequently induces and enhances 
apoptosis. In this study, we show that Cdc6 is also specifi  cally 
cleaved during apoptosis by caspase-3 at another aspartic acid 
residue, D290, yielding a truncation protein (p32-tCdc6) that 
accumulates in the nucleus under conditions in which cyclin 
A/Cdk2 activity is up-regulated. Interestingly, the expression of 
p32-tCdc6 or p49-tCdc6 markedly increases apoptosis in etoposide-
treated cells and induces apoptosis of untreated cells. Moreover, 
the expression of tCdc6 proteins induces activation of the ATM 
and ATR kinase. The expression of tCdc6 also suppresses the 
chromatin loading of the replication initiation factor Mcm2. 
  Importantly, tCdc6-induced effects are prevented in cells that 
coexpress a version of Cdc6 that cannot be cleaved by caspase-3 
(Cdc6-UM). Moreover, when ATM or ATR is down-expressed 
using the siRNA technique, caspase-3 activity is suppressed in 
TNF-α–induced cells. These results suggest that the caspase-
mediated cleavage of Cdc6 destabilizes the pre-RC and, thus, 
that tCdc6 proteins impair replication initiation by acting as 
dominant-negative inhibitors. This, in turn, results in the disrup-
tion of chromatin structure and/or induction of DNA damage, 
leading to ATM/ATR kinase–mediated apoptosis.
Results
Cdc6 is speciﬁ  cally cleaved at 
two sites by caspase-3 during 
etoposide-induced apoptosis
In etoposide-induced apoptosis of HeLa cells, the 62-kD Cdc6 
protein is specifi  cally cleaved into fragments of 49 and  36 kD, 
with kinetics similar to that of the proteolytic cleavage of poly 
(ADP-ribose) polymerase (PARP; Fig. 1 A). Cleavage at 
SEVD
442/G produces p49-tCdc6. To identify the second Cdc6 
Figure 1.  Caspase-3 speciﬁ   cally cleaves Cdc6 at two 
sites during etoposide-induced apoptosis. (A) Cdc6 un-
dergoes speciﬁ   c cleavages in HeLa cells treated with 
85 μM etoposide. Nuclear extracts were resolved by 12% 
SDS-PAGE and subjected to immunoblot analysis using 
anti-Cdc6 and anti-PARP antibodies. (B and C) Mutant 
and wt Cdc6 proteins were translated in vitro in the pres-
ence of [
35S]methionine and incubated at 30°C for 1 h 
with recombinant caspase-3. The reaction mixtures were 
resolved by 12% SDS-PAGE and visualized by autoradi-
ography. (D) Comparison of Cdc6 amino acid sequences 
and caspase-3 cleavage sites (underlining) from different 
species. (E) Caspase-3 cleavage sites and functional do-
mains of human Cdc6 that are responsible for interactions 
with other proteins are indicated.TCDC6 INDUCES DNA DAMAGE–TRIGGERED APOPTOSIS • YIM ET AL. 79
cleavage site, we constructed mutants in which asparagine is 
substituted for aspartic acid at one candidate site (DQLD
290/S) 
and at three other sequences (AGKD
262/M, LVLD
284/E, and 
KGQD
295/V) that are all in a region where cleavage would pro-
duce a fragment of  36 kD. Recombinant caspase-3 effi  ciently 
cleaved wild-type (wt) Cdc6 (Cdc6-wt) and the D262N, D284N, 
and D295N mutant proteins into 49- and 32-kD fragments 
(Fig. 1 B). In contrast, the D290N mutant was not cleaved, and 
this cleavage site was further confi  rmed with the double mutant 
protein D442N/D290N, which was resistant to caspase-3 cleavage, 
indicating that aspartic acid residues 290 and 442 are caspase-3 
cleavage sites during apoptosis (Fig. 1 C).
Interestingly, a 15–amino acid residue region including the 
DQLD
290/S cleavage site is well conserved among man, mouse, 
and Xenopus, whereas the region including the SEVD
442/G site 
is more loosely conserved (Fig. 1 D). Moreover, p32-tCdc6 and 
p49-tCdc6 contain all functional domains that are known to be 
essential for pre-RC loading (Fig. 1 E).
The cytoplasmic export of tCdc6 proteins 
is suppressed
We then assessed whether the p32-tCdc6 protein is functional 
for translocation into the cytoplasm because caspase cleavage 
removes the COOH-terminal nuclear export signal (NES) se-
quences. pCS2+GFP-tagged Cdc6-wt, tCdc6, or Cdc6-AAA, 
which is an unphosphorylatable mutant of Cdc6 on 54, 74, and 
106 serines, was cotransfected with pCMV-mock, cyclin A, or 
dominant-negative Cdk2 into HeLa cells. Cdc6-wt was trans-
located to the cytoplasm when cyclin A was coexpressed, 
whereas Cdc6-AAA was not even if cyclin A was coexpressed 
(Fig. 2, A and B). Although the cytoplasmic translocation of 
Cdc6-wt was mainly regulated by cyclin A/Cdk2-mediated 
phosphorylation (Fig. 2, A and B), the cytoplasmic transloca-
tion of p32-tCdc6 was relatively independent of cyclin A/Cdk2 
activity. The p32-tCdc6 protein was localized in the nucleus 
in 92% of the cells cotransfected with pCMV-mock, a higher 
percentage than for cells expressing p49-tCdc6 or Cdc6-wt 
(87 and 68%, respectively).
The differential distribution of p32-tCdc6 and p49-tCdc6 
was more signifi  cant when cyclin A was coexpressed. Under 
conditions of elevated cyclin A/Cdk2 activity, the cytoplasmic 
trans-localization of p32-tCdc6 was suppressed by 78% as 
  compared with that of Cdc6-wt (94 − 16%, because 94% of 
Cdc6-wt and 16% of p32-tCdc6 was localized in the cytoplasm). 
Under the same conditions, the translocation of p49-tCdc6 was 
suppressed by 57% (94 − 37%), as 37% of p49-tCdc6 was 
localized in the cytoplasm. Thus, p32-tCdc6 was more strongly 
retained in the nucleus (by 21%; 78 − 57%) as compared with 
the p49-tCdc6 protein under conditions of up-regulated cyclin 
A/Cdk2 activity. These results indicated that the p49-tCdc6 pro-
tein might contain an additional NES-like sequence between 
amino acid residues 290 and 442. In contrast, the cytoplasmic 
export of p49-tCdc6 and p32-tCdc6 was almost completely pre-
vented, as was the translocation of Cdc6-wt in cells expressing 
Cdk2-DN, resulting in nuclear localization in 99% of the trans-
fected cells (Fig. 2, A and B). 
Together, our data indicate that the phosphorylation of 
Cdc6-wt and tCdc6 proteins is essential for their cytoplasmic 
translocation and that the loss of a NES-like sequence from 
p49-tCdc6 reduces phosphorylation-dependent translocation. 
Our results showed that the majority of Cdc6-wt was translo-
cated to the cytoplasm, whereas the Cdc6-AAA mutant protein 
Figure 2.  Cleavage of Cdc6 induces nuclear accumulation of tCdc6 proteins. Cells were cotransfected with 1.5 μg each of pCS2+GFP–Cdc6-wt, –p49-
tCdc6, –p32-tCdc6, or –Cdc6-AAA and 1.5 μg each of pCMV-mock (M), pCMV–cyclin A (CyA), or dominant-negative pCMV-Cdk2 (DN) as indicated. 
(A) After 24 h, cells were ﬁ  xed and stained with DAPI. (B) The percentages of transfected cells in which Cdc6-wt, tCdc6, or Cdc6-AAA protein localizes to 
the nucleus were determined; data are expressed as means ± SD (error bars) from three determinations obtained in each of three experiments. (C) After 
24 h, cell extracts were prepared, resolved by 10% SDS-PAGE, and subjected to immunoblot analysis with speciﬁ  c antibodies against p-Cdc6 (S54), Cdc6, 
cyclin A, Cdk2, and actin. An asterisk denotes endogenous Cdc6.JCB • VOLUME 174 • NUMBER 1 • 2006  80
was mainly retained in the nucleus even if cyclin A was co-
expressed in the cells (Fig. 2, A and B). Also, Cdc6-wt, p49-tCdc6, 
and p32-tCdc6 but not Cdc6-AAA were all similarly phosphor-
ylated when they were prepared from cells that coexpressed 
  cyclin A. Phosphorylation was prevented in cells expressing 
Cdk2-DN (Fig. 2 C). Thus, tCdc6 proteins were similarly phos-
phorylated, but their phosphorylation-dependent cytoplasmic 
translocation was impaired by the loss of NES-like sequences in 
the region of 300–315 amino acid sequences.
Expression of tCdc6 proteins induces 
apoptosis and enhances the etoposide-
induced apoptosis of HeLa cells
We next tested the effect of p32-tCdc6 or p49-tCdc6 expression 
on apoptosis. Indeed, the expression of p32-tCdc6 notably en-
hanced etoposide-induced cell death to a greater extent than that 
of p49-tCdc6 (Fig. 3, A–C). The expression of either protein 
markedly increased the number of cells with apoptotic mor-
phology (membrane blebbing and cell shrinkage) to 95 and 
79%, respectively, whereas such changes occurred in <32% of 
cells expressing Cdc6-wt (Fig. 3 A). Similarly, the numbers of 
cells expressing tCdc6 that exhibited condensed DNA or that 
were Annexin V
+ and propidium iodide
− (PI
−) also signifi  cantly 
increased after treatment with etoposide (Fig. 3, B and C). 
In all cases, the apoptosis-promoting effects of p32-tCdc6 
  expression were higher than those induced by p49-tCdc6 
  expression. In addition, when pCS2+GFP-tagged p49- and 
p32-tCdc6 (1.5 μg cDNA of each) were cotransfected, the 
apoptosis-promoting effect was slightly lower than that induced 
by p32-tCdc6 (3 μg cDNA) but signifi  cantly higher than that 
induced by the same amount of p49-tCdc6 cDNA (Fig. 3, A–C). 
Also, apoptosis was clearly induced in cells expressing p32-
tCdc6 under normal HeLa cell culture conditions. The number 
of cells with apoptotic cell morphology increased by 78 and 
63% from 24 to 48 h after transfection in p32-tCdc6– or 
p49-tCdc6–expressed cells, respectively, whereas the expres-
sion of Cdc6-wt had a minimal effect (Fig. 3 D). Moreover, the 
sub-G1 proportion of cells expressing GFP-tagged p32-tCdc6 
increased to 21% over the course of 48 h, whereas <10% of 
cells expressing Cdc6-wt or the vector alone were in this 
sub-G1 proportion (Fig. 3 E). In addition, the Annexin V assay 
showed that the early apoptotic population of cells expressing 
p32-tCdc6 increased by three- to fourfold as compared with 
cells overexpressing Cdc6-wt or the vector 48 h after trans-
fection (Fig. 3 F). When p49- and p32-tCdc6 were coexpressed 
in the cells, the apoptosis-inducing effect increased in a time-
  dependent manner over the 48 h (Fig. 3, D–F). The results 
  indicated that in the coexpressed cells, the apoptosis-inducing 
effect is even higher than those induced by expressing p49- or 
p32-tCdc6 alone 48 h after transfection. Thus, the expression of 
tCdc6 proteins induces apoptosis in HeLa cells under normal 
cell culture conditions, and the differential effects of the two 
truncated versions of Cdc6 are consistent with their relative im-
pairments in export from the nucleus.
Figure 3.  Expression of tCdc6 proteins induces apoptosis and enhances etoposide-induced apoptosis in HeLa cells. (A–C) HeLa cells were transfected with 
3 μg pCS2+GFP-tagged Cdc6-wt or tCdc6 and incubated for 24 h, which were then treated with 85 μM etoposide (ET) for 12 h. For the cotransfection 
study, 1.5 μg of each pCS2+GFP–p49- and p32-tCdc6 was used. (A) The percentage of GFP-expressed cells showing membrane blebbing was deter-
mined after treatment with etoposide. (B) Transfected cells were stained with DAPI after treatment with etoposide, and the percentage of GFP-expressed cells 
with condensed DNA was quantiﬁ  ed. (C) The Annexin V assay was performed with the transfectants after treatment with etoposide as described in Mate-
rials and methods. The percentage of early apoptotic cells was calculated and is represented as a histogram. (D–F) HeLa cells were transfected with 3 μg 
pCS2+GFP-Cdc6. When p49- and p32-tCdc6 were coexpressed, 1.5 μg cDNA of each was used. (D) The images of transfected cells were collected by 
ﬂ  uorescence microscopy 24, 36, and 48 h afterward. The percentage of GFP-expressed cells showing membrane blebbing was quantitated. (E) FACS 
analysis was performed in a time-dependent manner after transfection. The proportion of cell populations in the sub-G1 among GFP
+ cells was calculated 
and is represented as a histogram. (F) The Annexin V assay was performed with transfectants expressing GFP in a time-dependent manner. The means ± SD 
(error bars) of data from at least three experiments are shown.TCDC6 INDUCES DNA DAMAGE–TRIGGERED APOPTOSIS • YIM ET AL. 81
Caspase-mediated cleavage of Cdc6 
interferes with pre-RC loading
To assess the functional relevance of the caspase-mediated 
cleavage of Cdc6, we fi  rst tested its effect on pre-RC loading. 
Both p49- and p32-tCdc6 bound chromatin with kinetics simi-
lar to that of PARP cleavage in cells treated with etoposide or 
TNF-α (Fig. 4, A and B). The kinetics of binding indicated that 
p49-tCdc6 bound before p32-tCdc6. Moreover, chromatin-
bound Mcm2 levels were strongly reduced, whereas the levels 
of chromatin-bound Orc2 remained unaltered in cells treated with 
etoposide or TNF-α. In addition, the reduced levels of chromatin-
bound Mcm2 temporally correlated with elevations in the level 
of chromatin-bound tCdc6 proteins (Fig. 4, A and B). Thus, the 
caspase-dependent cleavage of chromatin-bound Cdc6 inter-
fered with the binding of Mcm2 binding onto chromatin, but 
cleavage did not prevent tCdc6 proteins from binding chroma-
tin. Also, ectopically expressed tCdc6 proteins were specifi  cally 
incorporated onto chromatin and subsequently inhibited the 
binding of Mcm2 to chromatin, but they did not interfere with 
the loading of Orc2 onto chromatin in both asynchronized and 
early S phase cells (Fig. 4 C). Our results also indicate that the 
interaction of Mcm2 with tCdc6 proteins was markedly reduced 
as compared with the Mcm2–Cdc6-wt interaction in transfected 
cell extracts (Fig. 4 D). The cellular levels of Cdc6-wt and 
tCdc6 proteins were largely equivalent. In summary, these re-
sults indicate that the binding of tCdc6 proteins to chromatin 
interferes with the loading of DNA replication initiation factors, 
including Mcm2, onto replication complexes, thereby hindering 
the initiation of replication.
Expression of tCdc6 proteins induces 
apoptosis that involves DNA damage–
sensing kinase activation and elevation 
of p53–Bax complex formation
We then determined whether the tCdc6-induced impairment of 
Mcm2 loading onto chromatin is functionally linked to ATM and 
ATR kinase activities (Fig. 5 A). Interestingly, in cells expressing 
tCdc6, ATR and ATM kinase activities signifi  cantly increased in 
a time-dependent fashion 24–36 h after transfection, whereas 
their cellular protein levels were minimally altered. Moreover, 
in cells expressing tCdc6, the phosphorylated levels of Chk1 on 
S345 residue and Chk2 on T68 also markedly increased, with ki-
netics similar to those of the increases in ATM and ATR kinase 
activities (Fig. 5 B). In addition, the extent of phosphorylation on 
the S15 residue of p53, which is phosphorylated by ATM kinase, 
increased in parallel with increases in the p53 protein level in 
cells expressing tCdc6. These results indicate that the expression 
of tCdc6 is likely to disturb chromatin structures and/or induce 
DNA damage, leading to ATM and ATR kinase activation and, 
thus, to p53 protein stabilization during apoptosis.
The protein levels of Bax and p21, which are target 
  molecules of p53, also increased under the same conditions, 
Figure 4.  Truncation of the chromatin-bound Cdc6 inhibits loading of Mcm2 onto chromatin during etoposide- or TNF-𝗂–induced apoptosis. (A and B) 
HeLa cells treated with etoposide or TNF-α and cycloheximide (CHX) were collected, and nuclear fractions were isolated. Chromatin fractions were sepa-
rated as described in Materials and methods, and chromatin-bound proteins were detected with speciﬁ  c antibodies against Cdc6, PARP, Mcm2, and Orc2. 
(C) HeLa cells were transfected with 3 μg pCS2+GFP-tagged Cdc6-wt or tCdc6. After incubating for 24 h, asynchronized transfected cells or transfected 
cells that were synchronized in early S phase by treatment with hydroxyurea for 24 h were harvested. Chromatin and nucleosol proteins were resolved by 
SDS-PAGE and subjected to immunoblot analysis using speciﬁ  c antibodies against Cdc6, Orc2, and Mcm2. Error bars represent SD. (D) HeLa cell extracts 
were prepared 24 h after transfection and immunoprecipitated with an anti-GFP monoclonal antibody. Immunoprecipitates were resolved by SDS-PAGE 
and subjected to immunoblot analysis using the anti-Mcm2 and anti-Cdc6 antibodies. An asterisk denotes endogenous Cdc6. JCB • VOLUME 174 • NUMBER 1 • 2006  82
  indicating that the increased p53 level was functionally linked 
to induce Bax and p21 expression in tCdc6-expressing HeLa 
cells (Fig. 5 C). We next assessed the mitochondrial levels of 
Bax in cells expressing Cdc6-wt or tCdct6, as Bax is known 
to translocate to mitochondria during apoptosis (Gross et al., 
1998). As shown in Fig. 5 C, the mitochondrial levels of Bax 
in cells expressing tCdc6 increased in a time-dependent man-
ner, whereas the levels of mitochondrial VDAC, a mitochon-
drial marker protein, were unaltered. These results indicate that 
the mitochondrial translocation of Bax is promoted in cells 
expressing tCdc6 proteins. Interestingly, the levels of the p53–
Bax complex were also notably elevated in cells expressing 
tCdc6, whereas the complex was almost undetectable in cells 
expressing the vector or Cdc6-wt (Fig. 5 D). Moreover, Bax 
in association with the p53 protein was detected as a double 
band in cells expressing tCdc6, whereas Bax that was un-
associated with p53 was detected as a single band, suggesting 
that the upper band is a phosphorylated form (Fig. 5 D). These 
results also showed that the levels of mitochondrial Bax signifi  -
cantly increased in parallel with increases in the levels of p53 
in transfected cells (Fig. 5 C). Interestingly, the levels of p53 in 
mitochondria also increased in concert with increases in mito-
chondrial Bax 36 h after transfection in tCdc6-expressed cells 
(Fig. 5 E). These results indicate that tCdc6 expression induces 
an elevation in the cellular levels of the p53–Bax complex and 
that this increase may be involved in the mitochondrial translo-
cation of these proteins.
Proapoptotic effects induced by tCdc6 
are effectively blocked in cells expressing 
the uncleavable mutant of Cdc6
We asked whether an uncleavable mutant of Cdc6 (Cdc6-UM) 
has the effects described for tCdc6 that disturb Mcm2 loading 
to the chromatin and activate DNA damage–sensing kinase 
  activity and proapoptotic effect. As expected, Cdc6-UM was 
uncleaved, whereas Cdc6-wt was cleaved to p49-tCdc6 during 
TNF-α–induced apoptosis (Fig. 6 A). In addition, loading of 
the Mcm2 protein onto chromatin and ATR kinase activity were 
minimally infl  uenced in cells expressing Cdc6-UM. In con-
trast, Mcm2 chromatin loading was suppressed, whereas ATR 
kinase activity was prominently up-regulated in cells express-
ing p49-tCdc6 or p32-tCdc6 (Fig. 6, B and C; top). However, 
the tCdc6-induced up-regulation of ATR kinase activity was 
markedly suppressed by coexpressing Cdc6-UM (Fig. 6 C, 
bottom). Moreover, the percentage of p32-tCdc6–expressing 
cells with apoptotic cell morphology decreased by  45% 
(79.7 − 34.5% = 45.2%) over the time course of 36–48 h after 
coexpression with Cdc6-UM (Fig. 6 D). These competition 
 effects of Cdc6-UM on the tCdc6-induced events were  similarly 
observed when the cells were coexpressed with Cdc6-wt and 
tCdc6 (Fig. 6, C and D). These results indicate that the expres-
sion of tCdc6 impairs Mcm2 loading onto chromatin, which is 
functionally linked to ATM/ATR kinase activation leading to 
apoptosis, and that these effects are blocked by the expression 
of Cdc6-UM.
Figure 5.  Expression of tCdc6 triggers DNA 
damage–induced apoptosis. (A) HeLa cell ex-
tracts were prepared at various times after 
transfection, and ATM or ATR kinase was 
  immunoprecipitated with anti-ATM or anti-ATR 
antibody, respectively. ATM or ATR kinase was 
assayed in vitro with PHAS-1 as a substrate in 
the presence of γ-[
32P]ATP, resolved by 15% 
SDS-PAGE, and followed by autoradiography. 
Proteins were also resolved by 8% SDS-PAGE 
and subjected to immunoblot analysis with 
speciﬁ  c antibodies against ATM, ATR, Cdc6, 
and actin. (B) HeLa cell extracts were prepared 
30 h after transfection, and whole cell extracts 
were resolved by 10% SDS-PAGE and sub-
jected to immunoblot analysis with speciﬁ  c an-
tibodies against p53, p-p53 (S15), Chk1, 
pChk1 (S345), Chk2, pChk2 (T68), and actin. 
(C) Whole cell extracts and mitochondrial pro-
teins were prepared at various times after 
transfection, resolved by 12% SDS-PAGE, and 
subjected to immunoblot analysis using spe-
ciﬁ  c antibodies against p53, Bax, p21, actin, 
and VDAC. (D) Whole cell extracts were pre-
pared 30 h after transfection and immuno-
precipitated with an anti-p53 polyclonal antibody, 
and immunoprecipitates were resolved by 
SDS-PAGE and subjected to immunoblot analy-
sis using anti-p53 and anti-Bax antibodies. 
(E) Mitochondrial cell extracts were prepared 
from HeLa cells 36 h after transfection, re-
solved by 12% SDS-PAGE, and subjected 
to immunoblot analysis using corresponding 
speciﬁ  c antibodies.TCDC6 INDUCES DNA DAMAGE–TRIGGERED APOPTOSIS • YIM ET AL. 83
TNF-𝗂–induced apoptosis is strongly 
enhanced in cells expressing tCdc6, 
but death is suppressed in cells expressing 
the uncleavable mutant of Cdc6
We next addressed the possibility that TNF-α–induced cell 
death is infl  uenced by tCdc6 and Cdc6-UM. TNF-α–induced 
apoptosis, as measured by caspase-3 activity, was enhanced in 
cells expressing tCdc6 (Fig. 6 E). In contrast, the tCdc6-induced 
activation of caspase-3 was suppressed in cells expressing 
Cdc6-UM to a level that was lower than that exhibited by mock-
transfected cells treated with TNF-α but was still much higher 
than that of unexposed control cells. Thus, we tested whether 
tCdc6 expression promotes ATM kinase activity during TNF-α–
induced apoptosis. Interestingly, this activity was signifi  cantly 
elevated in HeLa cells 2 h after TNF-α treatment (Fig. 6 F). 
Moreover, TNF-α–induced kinase activation was clearly en-
hanced by about threefold in cells expressing p32-tCdc6 as 
compared with that in mock-transfected cells either untreated or 
treated with TNF-α. Again, TNF-α–induced caspase-3 activity 
was suppressed in cells expressing Cdc6-UM to levels even 
lower than those of cells expressing mock or Cdc6-wt (Fig. 6 E). 
Similarly, TNF-α–induced ATM kinase activity in cells expressing 
Cdc6-UM was at the basal level, which was similar to that in 
cells expressing mock (Fig. 6 G). Nevertheless, the kinase activ-
ity in Cdc6-UM–transfected cells was three- to fourfold lower 
than that in p32-tCdc6–expressed cells after TNF-α treatment. 
Thus, these results indicate that specifi  c cleavage of Cdc6 is 
likely functionally linked to ATM kinase activation during 
TNF-α–induced cell death in HeLa cells.
Down-expression of ATM or ATR 
suppresses tCdc6- or TNF-𝗂–induced 
apoptosis
To assess whether ATM or ATR kinase activation might be func-
tionally linked to apoptosis induced by expressing tCdc6 or treat-
ment with TNF-α, the expression level of ATM or ATR kinase
was specifi  cally down-regulated using the siRNA technique. 
24 h after transfection with siRNA for ATM or ATR, the cells 
were transfected with pCS2+GFP–Cdc6-wt or –p32-tCdc6. 
The results indicated that protein levels and the tCdc6-induced 
  activation of ATM or ATR kinase activity were similarly down-
regulated to basal levels in the cells by treatment with corre-
sponding siRNA (Fig. 7 A). Moreover, the p32-tCdc6–  induced 
activation of   caspase-3 activity was markedly   suppressed in the 
Figure 6.  Proapoptotic effects induced by tCdc6 are 
blocked in cells expressing caspase-uncleavable Cdc6. 
(A) HeLa cells were transfected with cDNA of Cdc6-wt 
or Cdc6-UM and, after incubating for 24 h, were 
treated with TNF-α and cycloheximide for 4 h. Cell ex-
tracts were subjected to immunoblot analysis using 
anti-Cdc6 and anti-actin antibodies. (B) Chromatin 
fractions were prepared 24 h after transfection and 
subjected to immunoblot analysis using anti-Cdc6, 
anti-Mcm2, and anti-Orc2 antibodies. (C) HeLa cells 
were transfected with 3 μg each of pCS2+GFP (M), 
pCS2+GFP-tagged Cdc6-wt (Wt), tCdc6s (p49 or 
p32), and Cdc6-UM (UM). When tCdc6s were coex-
pressed with Cdc6-wt or Cdc6-UM, 3 μg cDNA of 
each was used. 36 h later, whole cell extracts were 
prepared and assayed in vitro for ATR kinase activity 
as described in Fig. 5 A. (D) HeLa cells were trans-
fected with 3 μg each of pCS2+GFP-tagged Cdc6-wt, 
tCdc6s, and Cdc6-UM. When tCdc6 and Cdc6-wt or 
Cdc6-UM were cotransfected, 3 μg cDNA of each 
was used. The percentage of transfected cells exhibit-
ing apoptotic morphology was determined at 24, 36, 
and 48 h later. The means ± SD (error bars) of data 
from at least three experiments are shown. (E) 36 h 
  after transfection, HeLa cells were treated with TNF-α 
and cycloheximide (CHX) for 4 h. Cell extracts were 
assayed for caspase-3 activity using the ﬂ  uorogenic 
caspase-3–speciﬁ  c substrate Ac-DEVD-AFC. RFU, rela-
tive ﬂ  uorescent unit. (F) HeLa cells were treated with 
TNF-α and cycloheximide for the indicated times, and 
cell extracts were assayed in vitro for ATM kinase 
  activity as described in Fig. 5 A. (G) 24 h after trans-
fection, HeLa cells were treated with TNF-α and cyclo-
heximide for 2 h, and in vitro ATM kinase activities 
were similarly assessed by autoradiography.JCB • VOLUME 174 • NUMBER 1 • 2006  84
cells by treatment with siRNA of ATM or ATR (Fig. 7 B). Thus, 
apoptotic cell death induced by expressing tCdc6 was signifi  cantly 
suppressed by down-expressing ATM or ATR kinase in the cells. 
Interestingly, in the ATM or ATR down-expressed cells, the   levels 
of caspase-3 activity were even lower than those of cells expressing 
mock or Cdc6-wt (Fig. 7 B). These results indicated that apop-
totic cell death induced by transfection stress alone can be also 
suppressed by down-expressing ATM or ATR kinase in the cells. 
We next addressed whether the down-expression of ATM or ATR 
might also suppress the TNF-α–induced apoptosis. The TNF-α–
induced caspase-3 activity was similarly suppressed by  50% as 
compared with those in the control siRNA-treated cells by down-
expressing ATM or ATR in the cells (Fig. 7 C). These results indi-
cate that activation of ATM and ATR kinase activity is commonly 
required for tCdc6- or TNF-α–induced apoptosis of the cells.
Collectively, these results indicate that DNA damage–
sensing kinase activation may be linked to cellular increases in 
p53–Bax, which leads to the enhanced mitochondrial transloca-
tion of p53 and Bax with subsequent amplifi  cation of apoptosis 
induced by etoposide or TNF-α.
Discussion
We describe a novel functional role for caspase-mediated cleav-
age of Cdc6 during etoposide- or TNF-α–induced apoptosis. 
In particular, we show that Cdc6 truncation impairs Mcm2 load-
ing onto chromatin and subsequently activates DNA damage–
sensing kinase activities that may be linked to p53–Bax-mediated 
programmed cell death. Our fi  ndings have important implica-
tions for the functional role of Cdc6 in apoptosis and also for 
tCdc6-induced DNA damage signaling in enhancing apoptosis 
that is induced by treatment with etoposide or TNF-α.
Caspase-mediated truncation of Cdc6 
promotes apoptosis
Previous studies have suggested that Cdc6 is specifi  cally cleaved 
by caspase-3 during the early stages of apoptosis (Blanchard 
et al., 2002; Pelizon et al., 2002; Yim et al., 2003; Schories et al., 
2004), which leads to the nuclear accumulation of a tCdc6 frag-
ment, p49-Cdc6, and apoptosis (Yim et al., 2003). Moreover, the 
expression of a partially uncleavable mutant of HuCdc6 attenu-
ates or delays apoptosis (Pelizon et al., 2002). These results indi-
cate that the caspase-mediated cleavage of Cdc6 protein plays an 
important role early in apoptosis. Our results demonstrate that the 
Cdc6 caspase-3 cleavage sites SEVD
442/G and DQLD
290/S and 
residues immediately adjacent to these motifs are well conserved 
among different species (Fig. 1 D). Interestingly, the nuclear level 
of p32-tCdc6, which is produced by caspase-3 cleavage at the 
D
290 residue, is higher by 21% than that of p49-tCdc6, which is 
produced by cleavage at the D
442 residue under conditions of ele-
vated cyclin A/Cdk2 activity (Fig. 2). This discrepancy is likely 
caused by a novel NES sequence located between amino acid 
residues 290 and 442. Supporting this is that the p49-tCdc6 pro-
tein contains a leucine-rich NES-like sequence (consensus NES; 
LX(1–3)LX(2–3)LXL, where X is any amino acid; Henderson and 
Eleftheriou, 2000) in the region of amino acid sequences from 
300 to 315 amino acid residues. Moreover, the cytoplasmic trans-
location of the mutant version of Cdc6 protein, in that leucine 
residues at 311 and 313 are substituted with alanine residues, de-
creases by 30% as compared with that of Cdc6-wt in the cells that 
are overexpressing cyclin A (unpublished data). Apoptosis is 
more strongly promoted in cells expressing p32-tCdc6 than in 
cells expressing p49-tCdc6 after treatment with etoposide (Fig. 3). 
Furthermore, the apoptosis-promoting effects of tCdc6 proteins 
are consistent with their nuclear localizations (Figs. 2 and 3). 
These fi  ndings thus support our earlier hypothesis that caspase-
mediated cleavage of Cdc6 is functionally linked to the promo-
tion of apoptotic progression.
Caspase-mediated cleavage of Cdc6 
induces the perturbation of Mcm2 
loading onto chromatin
There are several lines of evidence suggesting that the func-
tional perturbation of DNA replication is a key process during 
Figure 7.  Down-expression of ATM or ATR suppresses 
tCdc6- or TNF-𝗂–induced apoptosis. (A and B) HeLa cells 
were transfected with a ﬁ  nal concentration of 100 nM 
siRNA duplexes for the control, ATM, or ATR. 24 h 
thereafter, pCS2+GFP-tagged Cdc6-wt or p32-tCdc6 
was transfected. HeLa cell extracts were prepared 
30 h after transfection, and whole cell extracts were 
resolved by 8% SDS-PAGE and subjected to immuno-
blot analysis with speciﬁ   c antibodies against ATM, 
ATR, Cdc6, or actin. For ATM or ATR kinase assay in 
vitro, ATM or ATR kinase was immunoprecipitated with 
anti-ATM or anti-ATR antibody, and the kinase activity 
was determined using PHAS-1 as a substrate in the 
presence of γ-[
32P]ATP followed by   autoradiography. 
Proteins were also assayed for caspase-3 activity using 
the ﬂ  uorogenic caspase-3–speciﬁ  c substrate Ac-DEVD-
AFC. An asterisk denotes endogenous Cdc6. (C) HeLa 
cells were transfected with a ﬁ   nal concentration of 
100 nM siRNA duplexes for control, ATM, or ATR. 
24 h later, transfected cells were treated with TNF-α 
and cycloheximide (CHX) for 4 h. Cell extracts 
were assayed for caspase-3 activity. The means ± SD 
(error bars) of data from at least three experiments are 
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DNA damage–triggered apoptosis. First, apoptosis is induced 
by defects in the initiation of DNA replication as a result of the 
orc2-1 mutation (Weinberger et al., 2005). In addition, temperature-
sensitive orc2-1 mutants cause a defect in a checkpoint and 
  initiation of DNA replication (Weinberger et al., 1999; Trabold 
et al., 2005). Second, replication initiation proteins are cleaved 
by caspase during apoptosis (Blanchard et al., 2002; Pelizon 
et al., 2002; Yim et al., 2003; Schories et al., 2004). Third, when 
the expression of proteins such as Cdc6, Mcm2, and Cdc45 is 
blocked by the siRNA technique, proliferation is inhibited, and 
apoptosis is induced in cancer cells (Feng et al., 2003). Thus, 
replication fork collapse induced by interfering with the pre-RC 
may be a general feature of the early stages of apoptosis.
Our results show that the loading of Mcm2 onto chromatin 
is perturbed during apoptosis induced by etoposide or TNF-α 
(Fig. 4, A and B). Moreover, this perturbed complex formation 
is temporally consistent with kinetics of caspase-mediated 
cleavage of Cdc6 during apoptosis. In addition, the kinetics of 
chromatin binding indicate that chromatin-bound Mcm2 levels 
are markedly reduced in cells treated with etoposide or TNF-α. 
The results also show that the reduced levels of chromatin-
bound Mcm2 temporally correlate with elevations in the level of 
chromatin-bound tCdc6 proteins (Fig. 4, A and B). Thus, the 
caspase-dependent cleavage of chromatin-bound Cdc6 inter-
feres with the binding of Mcm2 to chromatin and subsequently 
may perturb pre-RC formation.
Furthermore, ectopically expressed tCdc6 proteins are 
specifi   cally incorporated into the pre-RC and subsequently 
  inhibit the binding of Mcm2 to chromatin, but they do not in-
terfere with the loading of Orc2 onto chromatin in both 
asynchronized and early S phase cells (Fig. 4 C). Our results 
also indicate that the interaction of Mcm2 with tCdc6 proteins 
is markedly reduced as compared with the Mcm2–Cdc6-wt in-
teraction in transfected cell extracts (Fig. 4 D). These results in-
dicate that the binding of tCdc6 proteins to chromatin interferes 
with the loading of DNA replication initiation factors, including 
Mcm2, onto replication complexes, thereby hindering the for-
mation of the DNA pre-RC. Thus, the cleavage of Cdc6 is likely 
to perturb Mcm2 binding onto chromatin and, consequently, 
pre-RC formation.
Cleavage of Cdc6 is functionally linked to 
the activation of ATM/ATR kinase activity
As the Cdc6 cleavage perturbs Mcm2 loading onto chromatin, 
we assessed whether the cleavage of Cdc6 induces DNA damage. 
The activities of ATM kinase (Fig. 6 F) and ATR kinase 
(not depicted) are elevated in HeLa cells during TNF-α–induced 
apoptosis. Importantly, the activation kinetics of these kinase 
activities are consistent with those of Cdc6 cleavage in TNF-α–
induced apoptosis (Fig. 6). Moreover, as shown in Fig. 5 A, 
ATR and ATM kinase activities signifi  cantly increase in a time-
dependent fashion 24–36 h after transfection in tCdc6-expressed 
cells, whereas their cellular protein levels are minimally altered. 
Moreover, in cells expressing tCdc6, the phosphorylated levels 
of Chk1 on S345 residue, Chk2 on T68 residue, and p53 on S15 
residue also markedly increase, with kinetics similar to those of 
the increases in ATR and ATM kinase activities (Fig. 5 B). 
Thus, DNA damage–sensing kinases are activated in tCdc6-ex-
pressed cells. These results indicate that the expression of tCdc6 
is likely to disturb the pre-RC, which then leads to DNA dam-
age with subsequent activation of the DNA damage–sensing 
  kinase activities. However, we do not rule out a possibility that 
the expression of tCdc6 disrupts chromatin structures but does 
not induce DNA damage, as ATM activation may result from 
changes in the structure of chromatin (Bakkenist and Kastan, 
2003). We then addressed whether the p53-dependent apoptosis 
pathway might be involved in Cdc6 cleavage-induced  apoptosis. 
The results suggest that the levels of mitochondrial Bax signifi  -
cantly increase in parallel with increases in the levels of p53 in 
the tCdc6-expressed cells (Fig. 5 C). Interestingly, the levels of 
p53 in mitochondria also increase in concert with increases in 
mitochondrial Bax 36 h after transfection in the tCdc6-  expressed 
cells (Fig. 5 E). Collectively, these results suggest that the ex-
pression of tCdc6 induces the perturbation of the loading of 
Mcm2 onto chromatin, leading to ATM kinase activation, p53 
protein stabilization, and, consequently, to apoptosis.
Cdc6-UM suppresses tCdc6-induced 
ATM/ATR activation and apoptosis
As cells with Cdc6 protein being depleted cannot survive, it is 
not suitable to use Cdc6 knockout or knock-down for establish-
ing a causal involvement of Cdc6 in the induction of apoptosis. 
Therefore, we used three different methods to show that the 
  caspase-mediated cleavage of Cdc6 is functionally linked to 
apoptosis. First, we determined whether the tCdc6-induced 
apoptotic effects might be prevented in cells that overexpress 
a caspase-uncleavable Cdc6 mutant (Cdc6-UM). Second, we 
tested whether the tCdc6-induced apoptotic effects might be 
functionally linked to the activation of DNA damage–sensing 
kinase activities and, thereby, to p53–Bax-mediated apoptosis. 
Third, we assessed whether the TNF-α– or tCdc6-induced 
apoptotic cell death might be prevented by down-expressing 
ATM or ATR using the siRNA technique.
Our results show that the chromatin levels of Mcm2 
decrease in cells expressing tCdc6 (Fig. 4 C). This tCdc6-induced 
interference with Mcm2 loading onto chromatin is consistent 
with the apoptosis-promoting effects induced by tCdc6 (Figs. 3 
and 4 C). Importantly, tCdc6-induced apoptosis is effi  ciently 
  reduced to control levels by the coexpression of Cdc6-UM 
(Fig. 6 D). Moreover, apoptosis, as assessed by the induction of 
caspase-3 activity, is prominently enhanced in cells expressing 
tCdc6 after treatment with TNF-α, and this effect is suppressed 
in cells expressing Cdc6-UM (Fig. 6 E). Similarly, ATR kinase 
activity is up-regulated in cells expressing tCdc6, whereas 
tCdc6-induced kinase activation is effectively prevented in cells 
that coexpress tCdc6 and Cdc6-UM (Fig. 6 C).
It is noteworthy that the TNF-α–induced activation 
of ATM is not signifi  cantly suppressed to the level of mock-
  transfected cells in the presence of Cdc6-UM, although ATM 
kinase activity is markedly up-regulated in TNF-α–treated cells, 
and that activity further increases in cells expressing p32-tCdc6 
(Fig. 6 G). However, the TNF-α–induced proapoptotic effect, as 
measured by caspase-3 activity, is suppressed by expressing 
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that these assays were measured with the whole cell extracts, 
which were prepared from the cells that were only partially 
transfected with Cdc6-UM. Alternatively, the TNF-α–induced 
caspase-3 activity may also be involved in proteolytic cleavage 
of chromatin-bound proteins that consequently alters chromatin 
structures, leading to the activation of ATM kinase.
Collectively, these results suggest that the caspase-mediated 
cleavage of Cdc6 is not functionally involved in induction but 
rather facilitates apoptotic progression. Supporting this is that 
the sequential generation of p49 followed by p32 is not only 
consistent with kinetics of apoptotic progression in the cells 
  induced by treatment with etoposide or TNF-α but also with 
their inducing effects on the perturbation of pre-RC formation 
and on activation of the DNA damage–associated ATM/ATR 
kinase activity in the cells expressing corresponding tCdc6 
  proteins. Moreover, the p32-tCdc6– or TNF-α–induced activa-
tion of caspase-3 activity is signifi  cantly down-regulated as a 
result of the specifi  c down-expression of ATM or ATR kinase in 
the cells (Fig. 7). These results indicate that ATM or ATR kinase 
activity is functionally linked to apoptosis, and the activation 
of ATM or ATR kinase activity is important to the apoptosis 
  induced by tCdc6 or TNF-α.
Thus, the sequential generation of p49 and p32 protein 
fragments and their differential effect on the perturbation of 
Mcm2 loading onto chromatin (and thus of pre-RC and activa-
tion of DNA damage–sensing kinase activities) may refl  ect a 
possible mechanism that enables the amplifi  cation of apoptotic 
cell death.
A model for the mechanism 
of tCdc6-induced apoptosis promotion
Our studies suggest that the functional linkages between im-
pairments in pre-RC formation and apoptosis-promoting phe-
nomena are mediated by DNA damage–sensing kinase activities 
that subsequently regulate the mitochondrial translocation of 
p53–Bax (Figs. 4 and 5). In this study, we propose a model for 
the mechanism of the tCdc6-induced apoptotic effects to ex-
plain the suppression by Cdc6-UM of apoptosis induced by 
tCdc6 or by TNF-α treatment (Fig. 8). Pre-RC components are 
recruited to origins in a stepwise manner, beginning with the 
  origin RC (ORC). ORC recruits Cdc6 and Cdt1, which are both 
required for the subsequent loading of MCM proteins (Takeda 
and Dutta, 2005). Our results show that caspase-generated p49- 
and p32-tCdc6 are equally capable of binding to the pre-RC 
(Fig. 4, A and B). Both tCdc6 proteins contain the Walker A domain, 
a site that is required for ATP and chromatin binding and 
is essential for the stable interaction among ORC, Cdc6, and 
MCM proteins, and the Walker B domain, a site that is essential 
for ATP hydrolysis and MCM protein loading (Fig. 1 E; Herbig 
et al., 1999; Petersen et al., 1999; Delmolino et al., 2001; Cook 
et al., 2002; Frolova et al., 2002). However, the truncation of 
Cdc6   impairs the loading of Mcm2 onto chromatin (Fig. 4, A–C),
 indicating that the Cdc6 COOH-terminal sequences that are re-
moved by caspase-mediated cleavage may also be required for 
stable Cdc6–Mcm2 complex formation, as the affi  nity of tCdc6 
proteins for Mcm2 is much lower than that of wt Cdc6 (Fig. 4 D). 
Thus, the truncation of Cdc6 may remove the Mcm2-binding 
site on Cdc6 in the pre-RC and consequently hinder the subse-
quent loading of other initiation factors onto the pre-RC.
The present model illustrates how tCdc6 proteins can in-
duce DNA damage–sensing kinase activities that trigger p53–
Bax-mediated apoptosis. As shown in Fig. 8, tCdc6 proteins 
(pathway 1) cannot compete with Cdc6 in preformed pre-RCs, 
as Cdc6 is stably bound, whereas they can be inserted into newly 
forming pre-RCs, which then inhibits subsequent MCM loading 
(Fig. 8). In pathway 2 (Fig. 8), when Cdc6 in preformed pre-
RCs is cleaved by caspase, replication initiation factors such 
as MCM proteins dissociate from and thereby destabilize the 
pre-RC. In this case, however, exogenous tCdc6 cannot replace 
bound tCdc6 in preformed pre-RCs but can replace newly re-
cruited Cdc6 or tCdc6 produced by caspase-mediated cleavage 
of bound Cdc6. Thus, this model proposes that the expression 
of tCdc6 impairs newly forming but not previously established 
pre-RCs. Nevertheless, the caspase-mediated cleavage of Cdc6 
in preexisting pre-RCs promotes the dissociation of MCM pro-
tein and the subsequent activation of DNA damage–sensing 
  kinase activities. In support of this model, proapoptotic effects 
induced by tCdc6 expression are completely prevented in cells 
that coexpress Cdc6-UM, whereas TNF-α–induced effects are 
only partially suppressed in the presence of Cdc6-UM (Fig. 6). 
Figure 8.  A model for the mechanism of 
apoptosis induced by caspase-mediated cleav-
age of Cdc6. (Pathway 1) In apoptotic cells, 
soluble Cdc6, which is cleaved by caspase, 
cannot bind to preformed pre-RCs but can bind 
to developing pre-RCs and thus interfere with 
the binding of MCM to chromatin. (Pathway 2)
Caspase cleaves chromatin-bound Cdc6, and 
the resulting tCdc6 in preexisting pre-RCs 
  induces the dissociation of MCM proteins, 
whereas tCdc6 in developing pre-RCs inhibits 
the loading of MCM proteins. The impairment 
of pre-RC formation then disrupts chromatin 
structure and/or induces DNA damage with 
subsequent activation of ATM/ATR activities, 
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Also, the activation of ATM/ATR kinase activity is important 
to promote apoptosis triggered by tCdc6 or TNF-α (Fig. 7).
In summary, our work provides insights into a novel func-
tional role for Cdc6 during apoptosis. Caspase-mediated cleav-
age of Cdc6, which occurs early in this process, is likely a novel 
mechanism that promotes or accelerates apoptotic progression 
during etoposide- or TNF-α–induced apoptosis. Considering 
these fi  ndings together, we propose that Cdc6 may play an im-
portant role as a checkpoint to promote apoptosis.
Materials and methods
Materials
DME and FBS were obtained from Invitrogen. The transfection reagent 
Polyfect was purchased from QIAGEN, and Annexin V AlexaFluor568 
was purchased from Roche Diagnostics. Human recombinant TNF-α was 
obtained from Biosource International. Other chemical reagents were pur-
chased from Sigma-Aldrich.
Plasmids
Human Cdc6 cDNA was provided by R.S. Williams (University of Texas 
Southwestern Medical Center, Dallas, TX; GenBank/EMBL/DDBJ accession 
no. NM  _001254). Converting the Asp 262, 284, 290, 295, and 442 res-
idues of Cdc6 to Asn was accomplished by altering the Asp codons GAT 
or GAC to the Asn codons AAT or AAC, respectively, by the megaprimer 
method (Sambrook and Russell, 2001). The mutation was ﬁ  rst introduced 
by PCR with the mutagenic primers (5′-T  G  G  G  A  A  G  A  A  C  A  T  G  A  T  G  A  G  G  -3′, 
5′-G  G  T  A  T  T  G  A  A  C  G  A  G  A  T  G  G  -3′, 5′-T  C  A  A  C  T  G  A  A  C  A  G  C  A  A  A  G  -3′, 5′-A  G  G-
C  C  A  G  A  A  T  G  T  A  T  T  G  -3′, 5′-T  C  A  G  A  A  G  T  T  A  A  T  G  G  T  A  A  C  A  G  G  -3′), the forward 
primer (5′-A  A  G  G  A  T  C  C  C  C  T  C  A  A  A  C  C  C  G  A  T  C  C  C  A  G  -3′), and the reverse 
primer (5′-AAGGATCCT T  A  A  G  G  C  A  A  T  C  C  A  G  -3′), and the products were 
cloned into pCITE-4c
+ for in vitro transcription and translation. Cdc6-AAA 
(S54A, S74A, and D106A), an unphosphorylatable mutant of Cdc6 by 
cyclin A/Cdk2 in which Ser 54, 74, and 106 residues of Cdc6 were mu-
tated to Ala, was constructed by sequential single mutation using the PCR 
method (S54A, 5′-A  G  C  C  C  T  G  C  C  T  C  T  C  G  C  C  C  C  C  A  G  G  A  A  A  C  G  T  -3′; S74A, 
5′-C  C  C  A  T  T  T  A  C  C  T  C  C  T  T  G  T  G  C  T  C  C  A  C  C  A  A  A  G  C  A  A  G  G  -3′; and S106A, 
5′-A  A  T  C  A  G  C  T  G  A  C  A  A  T  T  A  A  G  G  C  T  C  C  T  A  G  C  A  A  A  A  G  A  G  A  A  C  T  A  G  -3′). All 
mutants were conﬁ  rmed by DNA sequencing. To monitor mammalian ex-
pression, Cdc6 was inserted into the vector pCS2+GFP by amplifying 
full-length Cdc6 cDNA (encoding aa 1–560), p49-tCdc6 cDNA (encoding 
aa 1–442), or p32-tCdc6 cDNA (encoding aa 1–290). Full-length human 
cyclin A cDNA was generated by RT-PCR (using oligomers 5′-A  A  G  G  A  T  C-
C  A  G  C  C  T  A  T  T  C  T  T  T  G  G  C  C  -3′ and 5′-A  A  G  G  A  T  C  C  G  G  C  A  G  C  T  G  G  C  A  T  C  A  T  T-
A  A  T  A  C  -3′ with BamHI sites at the 5′and 3′ ends) and was cloned into the 
pCMV expression vector.
RNA interference
siRNA duplexes for ATM, ATR, and the control nontargeting siRNA were 
purchased from Dharmacon. The siRNA sequences (sense strand) for ATM 
and ATR were U  A  U  A  U  C  A  C  C  U  G  U  U  U  G  U  U  A  G  U  U   and G  C  A  A  C  U  C  G  C  C  U  A-
A  C  A  G  A  U  A  U  U  , respectively. 5 × 10
5 HeLa cells in 35-mm dishes were 
transfected with a ﬁ  nal concentration of 100 nM siRNA duplexes using 
Oligofectamine (Invitrogen) according to the manufacturer’s instructions.
Coupled in vitro transcription/translation of Cdc6 and in vitro 
cleavage assay
The in vitro transcription and translation of cDNAs encoding the human 
Cdc6 protein and the Cdc6 substitution mutants were performed with the 
TNT Coupled Reticulocyte Lysate System (Promega) according to the manu-
facturer’s protocols. For in vitro cleavage by caspase-3, 2 μl [
35S]methionine-
labeled Cdc6 was incubated with 100 ng recombinant caspase-3 as 
described previously (Yim et al., 2003).
Cell culture, transfection, apoptotic induction, and ﬂ  uorescence 
microscopy analysis
Human cervical carcinoma (HeLa) cells were maintained at 37°C and 5% 
CO2 as a monolayer culture in DME supplemented with 10% (vol/vol) 
heat-inactivated FBS, 100 units/ml penicillin, 100 μg/ml streptomycin, 
and 250 ng/ml amphotericin B. HeLa cells were transfected in 35-mm 
dishes with 3 μg of the appropriate plasmids using 12 μl Polyfect according 
to the manufacturer’s instructions. For apoptotic induction, cells were 
treated with 85 μM etoposide or 5 ng/ml TNF-α and 5 μg/ml cycloheximide. 
As TNF-α alone had no effect on HeLa cell viability, protein synthesis inhibitor 
cycloheximide was used together with TNF-α for the induction of apoptosis 
in HeLa cells (Miura et al., 1995). For DAPI staining, cells were ﬁ  xed in 
4% PFA solution as described previously (Yim et al., 2003).
Annexin V assay
The Annexin V assay was performed as described previously (Yim et al., 
2003). The percentage of Annexin V–positive cells and PI-negative cells 
among GFP-expressing cells was determined by ﬂ  ow cytometry (Particle 
Analyzing System PAS-III; Partec). Transfected cells were selectively ana-
lyzed by gating a subpopulation by forward scatter versus side scatter fol-
lowed by gating green ﬂ  uorescence intensity. Because the percentage of 
Annexin V
+ cells indicates the frequency of total apoptotic cells and the 
percentage of PI
+ cells indicates the frequency of late apoptotic and ne-
crotic cells, the apoptotic index of early apoptotic cell populations was cal-
culated by subtracting the percentage of PI
+ from the percentage of 
Annexin V
+.
FACS analysis
For determination of the sub-G1 fraction as an apoptotic index, cells ex-
pressing GFP-tagged proteins were collected over time and ﬁ  xed in 75% 
ethanol, stained with 500 μl of 50 μg/ml PI solution, and subjected to 
FACS analysis. GFP-expressing cells were selectively analyzed for DNA 
content followed by gating green ﬂ  uorescence intensity.
Immunoblot analysis and immunoprecipitation pull-down assay
HeLa cells expressing Cdc6 were collected and extracted in lysis buffer 
(0.5% Triton X-100, 20 mM Tris, pH 7.5, 2 mM MgCl2, 1 mM DTT, 1 mM 
EGTA, 50 mM β-glycerophosphate, 25 mM NaF, 1 mM Na vanadate, 
2 μg/ml leupeptin, 2 μg/ml pepstatin A, 1 μg/ml antipain, and 100 μg/ml
PMSF). Cell lysates were centrifuged at 12,000 rpm for 15 min at 4°C, 
and the supernatants were collected. After adjusting the protein concentra-
tion, proteins were resolved by SDS-PAGE before Western blot analysis 
with appropriate antibodies. Monoclonal anti-Cdc6, anti-GFP, anti-ATM, 
anti-p53, and anti-Chk2 antibodies and polyclonal anti-PARP, anti–p-Cdc6 
(S54), anti–cyclin A, anti-Cdk2, anti-Chk1, anti-ATM, anti-ATR, anti-Bax, 
and anti-VDAC antibodies were obtained from Santa Cruz Biotechnology, 
Inc. Polyclonal phospho-p53 (S15), phospho-Chk2 (T68), and phospho-
Chk1 (S345) antibodies were purchased from Cell Signaling Technology. 
Polyclonal anti-Mcm2 antibody was obtained from BD Biosciences. Immune 
complexes were revealed using ECL Western blotting detection reagents 
(Intron Biotechnologies). For immunoprecipitation reaction, p53 or GFP 
was precipitated from cell lysates with an anti-p53 polyclonal antibody or 
anti-GFP monoclonal antibody overnight at 4°C with end-over-end mixing 
followed by incubation with protein A agarose for 2 h at 4°C. Immuno-
precipitates were separated from supernatants by centrifugation and washed 
with lysis buffer. Proteins were extracted from agarose beads by resuspen-
sion in 1× laemmli gel-loading buffer and resolved by SDS-PAGE. For the 
detection of mitochondrial proteins, mitochondrial fractions were extracted 
in lysis buffer. Mitochondrial proteins were resolved by SDS-PAGE before 
Western blot analysis with anti-p53, anti-Bax, and anti-VDAC antibodies.
Preparation of nuclear and mitochondrial extracts
Nuclear and mitochondrial extracts were prepared as described previ-
ously (Buckley et al., 1999).
Chromatin-binding assay
Chromatin was fractionated with Triton X-100 as described previously 
(Okuno et al., 2001) with slight modiﬁ  cations. To synchronize 24 h after 
transfection, cells were treated with 2.5 mM hydroxyurea for 24 h. The 
nuclear fraction of HeLa cells (2 × 10
6) expressing Cdc6 was prepared 
and resuspended in 300 μl Cytoskeleton buffer containing 0.5% Triton 
X-100. For nuclease digestions, chromatin pellets were resuspended in 
lysis buffer including 25 units of benzonase nuclease and incubated at 
37°C for 10 min followed by chilling on ice and centrifugation. 20 μg 
of the supernatants were boiled with loading buffer and resolved by 10% 
SDS-PAGE before Western blot analysis with anti-Cdc6, anti-Orc2, and 
anti-Mcm2 antibodies.
ATM/ATR kinase assay
ATM or ATR kinase was immunoprecipitated from tCdc6-overexpressing 
HeLa cells with anti-ATM or anti-ATR polyclonal antibody in buffer (0.5% 
Triton X-100, 20 mM Tris, pH 7.5, 2 mM MgCl2, 1 mM DTT, 1 mM EGTA, JCB • VOLUME 174 • NUMBER 1 • 2006  88
50 mM β-glycerophosphate, 25 mM NaF, 1 mM Na3VO4, 2 μg/ml leu-
peptin, 2 μg/ml pepstatin A, 100 μg/ml PMSF, and 1 μg/ml antipain) fol-
lowed by incubation with protein A agarose at 4°C for 2 h. The reactions 
for ATM or ATR kinase activity were performed using 1 μg PHAS-1 (Calbio-
chem) as a substrate in reaction buffer (50 mM Tris, pH 7.5, 10 mM 
MgCl2, 1 mM DTT, 1 mM EGTA, 50 mM β-glycerophosphate, 25 mM NaF, 
0.1 mM Na3VO4, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 1 μg/ml anti-
pain, and 100 μg/ml PMSF) containing immunoprecipitated ATM protein 
or ATR protein and 10 μCi γ-[
32P]ATP at 30°C for 30 min. The reacted 
samples were suspended in SDS loading buffer, resolved by SDS-PAGE, 
and detected by autoradiography.
Fluorometric caspase-3 activity assay
50 μg of transfected cell lysates were incubated with 200 nM Ac-DEVD-
AFC (BD Biosciences) in reaction buffer (20 mM Hepes, pH 7.4, 100 mM 
NaCl, 10 mM DTT, 0.1% CHAPS, and 10% sucrose) at 37°C for 1 h. The 
reaction was monitored by ﬂ  uorescence emission at 535 nm (excitation 
at 405 nm).
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